Inflammation and changes in metabolic syndrome abnormalities in US adolescents: Findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys

Clinical Chemistry

Volumn 52, Issue 7, 2006, Pages 1325-1330

  De Ferranti, Sarah D ^a   Gauvreau, Kimberlee ^a   Ludwig, David S ^a   Newburger, Jane W ^a   Rifai, Nader ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; ETHNIC AND RACIAL GROUPS; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; REVIEW; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; CHOLESTEROL, HDL; FASTING; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; INFLAMMATION; MALE; METABOLIC SYNDROME X; OBESITY;

EID: 33745434546     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.067181     Document Type: Review

References (34)

1. Ronnemaa T, Knip M, Lautala P, Viikari J, Uhari M, Leino A, et al. Serum insulin and other cardiovascular risk indicators in children, adolescents, and young adults. Ann Med 1991;23:67-72.
2. Berenson GS, Srinivasan SR, Bao W. Precursors of cardiovascular risk in young adults from a biracial (black-white) population: the Bogalusa Heart Study. Ann N Y Acad Sci 1997;817:189-98.
3. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-7.
4. Katzmarzyk PT, Perusse L, Malina RM, Bergeron J, Despres JP, Bouchard C. Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: the Quebec Family Study. J Clin Epidemiol 2001;54:190-5.
5. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
6. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-22.
7. National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf (accessed January 10, 2004).
8. Pladevall M, Singal B, Williams LK, Brptons C, Guyer H, Sadurni J, et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 2006;29:113-22.
9. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004;110:2494-7.
10. Dodson PM, Shine B. Retinal vein occlusion: C-reactive protein and arterial hypertension. Acta Qphthalmol (Copenh) 1984;62:123-30.
11. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-6.
12. Aronson D, Bartha P, Zinder O, Kerner A, Markiewicz W, Avizohar O, et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord 2004;28:674-9.
13. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 2004;50:1762-8.
14. Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2003;108:1053-8.
15. National Center for Health Statistics. Centers for Disease Control and Prevention. Analytic and reporting guidelines: the Third National Health and Nutrition Examination Survey, NHANES III (1988-94). http://www.cdc.gov/nchs/ data/nhanes/nhartes3/nh3gui.pdf (accessed September 10, 2004).
16. National Center for Health Statistics. Centers for Disease Control and Prevention. NHANES 1999-2000 addendum to the NHANES III analytic guidelines. http://www.cdc.gov/nchs/data/nhanes/guidelines1.pdf (accessed September 10, 2004).
17. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 2005;28:878-81.
18. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 2001;138:486-92.
19. Moran A, Steffen LM, Jacobs DR Jr, Steinberger J, Pankow JS, Hong CP, et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care 2005;28:1763-8.
20. Ogden CL, Regal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288:1728-32.
21. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004;291:2847-50.
22. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000;149:139-50.
23. Isasi CR, Deckelbaum RJ, Tracy RP, Starc TJ, Berglund L, Shea S. Physical fitness and C-reactive protein level in children and young adults: the Columbia University BioMarkers Study. Pediatrics 2003;111:332-8.
24. Wu DM, Chu NF, Shen MH, Chang JB. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol 2003;56:94-100.
25. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001;107:E13.
26. Shea S, Aymong E, Zybert P, Shamoon H, Tracy RP, Deckelbaum RJ, et al. Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. Obes Res 2003;11:95-103.
27. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
28. Ford ES, Giles WH, Myers GL, Rifai N, Ridker PM, Mannino DM. C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem 2003;49:1353-7.
29. Vanhala MJ, Vanhala PT, Keinanen-Kiukaanniemi SM, Kumpusalo EA, Takala JK. Relative weight gain and obesity as a child predict metabolic syndrome as an adult. Int J Obes Relat Metab Disord 1999;23:656-9.
30. Lee WY, Park JS, Noh SY, Rhee EJ, Sung KC, Kim BS, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol 2004;97:101-6.
31. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-7.
32. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-9.
33. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
34. Acton KJ, Rios Burrows N, Moore K, Querec L, Geiss LS, Engelgau MM. Trends in diabetes prevalence among American Indian and Alaska native children, adolescents, and young adults. Am J Public Health 2002;92:1485-90.